Search results
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters via Yahoo News· 1 week agoPatrik Jonsson, President of Lilly Diabetes and Obesity, speaking at a Goldman Sachs healthcare...
Eli Lilly appoints new obesity unit head ahead of key Mounjaro decision
Reuters via Yahoo Finance· 8 months agoMounjaro, chemically known as tirzepatide, is already being prescribed by doctors off-label as an...
Eli Lilly names new head of diabetes and obesity division in leadership shakeup
United Press International via Yahoo News· 8 months agoEli Lill and Company Wednesday announced several executive leadership transitions as executive vice...
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 months agoImage source: The Motley Fool. Eli Lilly (NYSE: LLY) Q1 2024 Earnings Call Apr 30, 2024, 10:00 a.m. ET Contents: Prepared Remarks Questions and Answers...
Q4 2023 Eli Lilly and Co Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 months agoParticipants Anat Ashkenazi; Executive VP & CFO; Eli Lilly and Company Daniel M. Skovronsky; EVP, Chief Scientific Officer and President of Lilly Research Laboratories & Lilly immunology; Eli ...
Eli Lilly exec expects obesity pill data in April 2025
Reuters via AOL· 1 week agoThe pill is part of a class of drugs known as incretins designed to mimic the action of the GLP-1...
Shares of Eli Lilly, Dice Therapeutics Gain on Acquisition Announcement
GuruFocus.com via Yahoo Finance· 12 months agoLooking to enhance its product portfolio for immune-related diseases, an area where it has lagged...
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Yahoo Finance· 1 week agoEli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound —...
Supplies of Wegovy and Other Weight Loss Drugs Can Now Be Tracked by Patients
Gizmodo via Yahoo News· 3 weeks agoAs Novo Nordisk and Eli Lilly struggle to keep up with soaring demand for their popular diabetes and...
Eli Lilly Hits New High As It Tempts Investors With Buy Zone
Investor's Business Daily· 1 year agoPharma giant Eli Lilly hit a new high Friday and is in the 5% buy zone, waiting for investors to...